Skip to main content
Journal ArticleOPEN ACCESS

Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada

Open Forum Infectious Diseases (2021) 8(11)
DOI: 10.1093/ofid/ofab492
1Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Initiation of human immunodeficiency virus preexposure prophylaxis (PrEP) medications will also treat hepatitis B infection (HBV). The prevalence of chronic HBV was 0.86% (n = 41/4760) among enrollees in a provincial PrEP program in British Columbia, Canada. Overall, 46.3% lacked follow-up HBV DNA monitoring, underscoring the need for HBV-related education for PrEP prescribers.

Author supplied keywords

Cite

CITATION STYLE

APA

Thompson, K. A., Blank, G., Toy, J., Moore, D. M., Lachowsky, N., Bacani, N., … Hull, M. W. (2021). Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada. Open Forum Infectious Diseases, 8(11). https://doi.org/10.1093/ofid/ofab492

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free